| POMC |
P01189
|
proopiomelanocortin
|
|
1.2E-04 |
0.356 |
0.846 |
238
|
| IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
169
|
| CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
168
|
| IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
157
|
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
96
|
| EPO |
P01588
|
erythropoietin
|
|
1.1E-02 |
0.381 |
0.885 |
84
|
| TLR4 |
O00206
|
toll like receptor 4
|
|
4.6E-09 |
0.321 |
0.962 |
76
|
| IL2 |
P60568
|
interleukin 2
|
|
0.48 |
0.336 |
0.885 |
73
|
| CLU |
P10909
|
clusterin
|
|
7.8E-05 |
0.426 |
0.885 |
65
|
| PARP1 |
P09874
|
poly(ADP-ribose) polymerase 1
|
|
3.3E-04 |
0.389 |
0.923 |
62
|
| NPPA |
P01160
|
natriuretic peptide A
|
|
5.5E-04 |
0.505 |
0.769 |
61
|
| COL2A1 |
P02458
|
collagen type II alpha 1 chain
|
|
1.00 |
0.444 |
0.846 |
59
|
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
49
|
| APEX1 |
P27695
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
|
1.9E-07 |
0.458 |
0.846 |
38
|
| PAX6 |
P26367
|
paired box 6
|
|
1.00 |
0.450 |
0.769 |
37
|
| MITF |
O75030
|
melanocyte inducing transcription factor
|
|
0.98 |
0.499 |
0.808 |
30
|
| EP300 |
Q09472
|
E1A binding protein p300
|
|
1.00 |
0.459 |
0.846 |
27
|
| PRAME |
P78395
|
preferentially expressed antigen in melanoma
|
|
2.4E-07 |
0.531 |
0.577 |
27
|
| XRCC3 |
O43542
|
X-ray repair cross complementing 3
|
|
1.9E-10 |
0.505 |
0.769 |
27
|
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
24
|
| CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
21
|
| CDKN1C |
P49918
|
cyclin dependent kinase inhibitor 1C
|
|
0.82 |
0.456 |
0.846 |
18
|
| FTO |
Q9C0B1
|
FTO alpha-ketoglutarate dependent dioxygenase
|
|
8.4E-08 |
0.486 |
0.885 |
18
|
| FAT4 |
Q6V0I7
|
FAT atypical cadherin 4
|
|
1.00 |
0.539 |
0.808 |
17
|